Table 2.
Table 2a. IgG1 Antibody levels across age groups in an area of stable malaria transmission
| |||||
---|---|---|---|---|---|
Antigen | Median level (AU) (min, max) for age groups:
|
P value a (trend for age) | |||
2–5 yr (n=14) | 6–15 yr (n=30) | 16–40 yr (n=44) | >40 yr (n=28) | ||
CSP | 2.54 (0.40,9.37) | 3.21 (0.33,12.00) | 1.85 (0.00,11.19) | 2.74 (0.06,18.42) | 0.259 |
LSA-1 | 2.35 (0.16,16.05) | 2.19 (0.49,21.89) | 2.08 (0.49,41.30) | 2.38 (0.07,11.12) | 0.835 |
TRAP | 1.32 (0.02,7.44) | 1.56 (0.31,6.28) | 1.98 (0.56,5.32) | 2.01 (0.31,9.20) | 0.010 |
AMA-1 | 1.05 (0.08,4.78) | 2.31 (0.30,4.21) | 1.30 (0.00,4.87) | 1.36 (0.31,5.19) | 0.135 |
EBA-175 | 2.27 (0.02,11.83) | 9.58 (0.87,64.52) | 8.58 (0.92,58.89) | 6.35 (1.30,55.83) | 0.123 |
MSP-1 | 1.31 (0.15,2.51) | 1.64 (0.20,8.18) | 1.71 (0.40,9.93) | 1.74 (0.71,6.14) | 0.211 |
Table 2b. IgG1 Antibody levels across age groups in an area of unstable malaria transmission
| |||||
---|---|---|---|---|---|
Antigen | Median level (AU) (min, max) for age groupsb:
|
P value a (trend for age) | |||
2–5 yr (n=19) | 6–15 yr (n=12) | 16–40 yr (n=37) | >40 yr (n=28) | ||
CSP | 0.05 (0.00,4.86)* | 0.00 (0.00,1.02)* | 0.85 (0.02,3.29)* | 0.90 (0.29,3.52)* | <0.001 |
LSA-1 | 0.53 (0.24,10.97)* | 0.53 (0.03,2.40)* | 0.67 (0.20,3.91)* | 1.00 (0.12,15.95)* | 0.055 |
TRAP | 0.45 (0.14,2.07)* | 0.26 (0.13,1.28)* | 0.52 (0.00,4.40)* | 1.12 (0.19,3.81)* | <0.001 |
AMA-1 | 0.18 (0.00,2.46)* | 0.25 (0.00,2.32)* | 0.57 (0.01,2.91)* | 1.07 (0.24,4.08) | <0.001 |
EBA-175 | 0.63 (0.08,3.90)* | 0.99 (0.16,18.69)* | 2.76 (0.12,63.50)* | 26.61 (0.44,60.07) | <0.001 |
MSP-1 | 0.83 (0.24,1.62)* | 0.79 (0.16,1.69)* | 1.43 (0.30,5.52) | 2.31 (0.18,6.68) | <0.001 |
Non-parametric test for trend across ordered groups (see Materials and Methods)
Asterisk (*) indicates significantly different from antibody level for same antigen and age group in stable transmission area (P<0.05 by Wilcoxon rank-sum test).